Malignant astrocytomas are brain tumors that are locally infiltrative and incurable, with poor prognosis for the patient. Despite profound therapeutic implications, the identity of the cell(s) of origin of these tumors has not been rigorously determined. In addition, glioblastoma multiforme, the most prevalent and deadly form of brain tumor, can either progress from lower grade astrocytic gliomas or arise de novo, the mechanisms by which are not well understood. We previously reported mouse models based on conditional inactivation of human astrocytoma-relevant tumor suppressors p53, Nf1, and Pten, wherein through somatic loss of heterozygosity, mutant mice develop tumors that histologically and molecularly resemble human astrocytomas with 100% penetrance. In the present application, we propose experiments designed to investigate the cell(s) of tumor origin and to extend our analyses of tumorigenesis in these mouse models. To this end, Specific Aim 1 rigorously tests our hypothesis that gliomas originate in stem/progenitor cells. Our research design utilizes genetic and stereotactic methods to mutate the tumor suppressor genes specifically in the stem cell niche. We will also use a genetic method to ablate these neural stem cells in our tumor models and then analyze the effect on tumor formation.
Specific Aim 2 will exploit our ability to culture fresh tumor tissue as self-renewable neurospheres to further characterize our Nf1;p53;Pten """"""""de novo"""""""" glioma mouse model. We will evaluate their growth and differentiation properties, as well as their tumorigenic potential via transplantation techniques. Additionally, using a stem cell-specific GFP transgenic mouse, we will analyze the expression of candidate cell surface markers with the aim of identifying """"""""signature markers"""""""" that will allow us to prospectively isolate the cancer stem cells.
Specific Aim 3 will employ microarray analyses to identify the gene expression profiles that correlate with de novo vs. progressive glioma, using neurospheres derived from Nf1;p53;Pten and Nf1;p53 tumors, respectively. We also propose to analyze tissue from pre-symptomatic mice in order to gain insight into the early molecular events of tumor initiation. Potentially interesting genes will be functionally pursued using RNAi and overexpression techniques. As microRNAs have recently been implicated in glioma, we will also use microarray analysis to identify microRNAs that are differentially regulated in our tumor models and also investigate the role of candidate microRNAs in glioma. Our fully penetrant glioma mouse models are clinically relevant and powerful tools for identifying and functionally characterizing novel genes and pathways that may be therapeutically tractable in human glioma.
Malignant astrocytomas are the most common type of brain tumors that occur in adults and due to their infiltrative and aggressive nature, are virtually incurable. The focus of our research is to use mouse brain tumor models to identify and analyze genes that are involved in brain tumor initiation and progression. The hope is that by identifying these genes, we might begin to find suitable drug targets and develop therapies that would eliminate or inhibit the growth of these devastating tumors.
| Alcantara Llaguno, Sheila R; Parada, Luis F (2016) Cell of origin of glioma: biological and clinical implications. Br J Cancer 115:1445-1450 |
| Alcantara Llaguno, Sheila R; Xie, Xuanhua; Parada, Luis F (2016) Cell of Origin and Cancer Stem Cells in Tumor Suppressor Mouse Models of Glioblastoma. Cold Spring Harb Symp Quant Biol 81:31-36 |
| Alcantara Llaguno, Sheila R; Wang, Zilai; Sun, Daochun et al. (2015) Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes. Cancer Cell 28:429-440 |
| Zong, Hui; Parada, Luis F; Baker, Suzanne J (2015) Cell of origin for malignant gliomas and its implication in therapeutic development. Cold Spring Harb Perspect Biol 7: |
| Chen, Jian; Li, Yanjiao; Yu, Tzong-Shiue et al. (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488:522-6 |
| Chen, Jian; McKay, Renee M; Parada, Luis F (2012) Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell 149:36-47 |
| Lim, Sang Kyun; Llaguno, Sheila R Alcantara; McKay, Renee M et al. (2011) Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models. BMB Rep 44:158-64 |
| Hambardzumyan, Dolores; Parada, Luis F; Holland, Eric C et al. (2011) Genetic modeling of gliomas in mice: new tools to tackle old problems. Glia 59:1155-68 |
